Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data.

BMJ · 2015 · PMC4553205 · PMID 26321114

Europe PMC DOI

hedged sentence

0.0400

closest p · 0.8× alpha

0.0400

boldest claim

The sentences

of borderline significanceP=0.04actually significant

In studies that enrolled only patients with heart failure and/or atrial fibrillation, the risk of death associated with digoxin use was of borderline significance (hazard ratio 1.16, 1.05 to 1.28; P=0.04).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.